跳至主要内容
临床试验/ACTRN12610000245099
ACTRN12610000245099尚未招募4 期

Effects of Parecoxib, a selective cyclooxygenase-2 inhibitor,on liver function in Patients Undergoing hepatectomy of hepatic carcinoma: A Double-Blind, Randomized, Comparative Study

jinmin zhang0 个研究点目标入组 60 人开始时间: 2010年3月24日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1.elective liver resection 2. American Society of Anesthesiologists (ASA) physical status 2-3 patients 3.Primary liver cancer patients who had history of hepatitis B related cirrhosis 4.undergoing combine general and epidural anesthesia

排除标准

  • 1contradictions of epidural puncture including coagulate disorder (prothrombin time (PT) longer than 15 sec or/and blood platelets count less than 10,000 ).
  • 2.tumor size too small or too large(longitude of tumor was beyond 3-8 cm ) or estimated blood loss was large than 1000 cc.
  • 3.Individuals in whom the regional block failed and surgery was performed under general anesthesia alone were also withdrawn from the study..
  • 4.Patients with a known allergy to NSAIDs
  • 5.Patients who had received chemotherapy and radiation prior to surgery
  • 6.patients who with a history of peptic ulceration, or renal, cardiac, endocrine
  • 7. Patients who had received Non steroidal anti-inflammatory drugs (NSAIDs) within 14 days before enrollment

研究者

发起方
jinmin zhang

相似试验